Microbial eczema: possibilities of correction at the present stage

Cover Page

Abstract


Microbial eczema is a chronic recurrent dermatosis characterized by evolutionary polymorphism of the elements of the rash, sputum, itching, allergic reaction of the sensitized skin to the products of the decay of microorganisms and their toxins, developing against the background of a long-existing pyogenic focus in violation of the most important regulatory systems of the body.
Purpose: to study the biocenosis of the skin in patients with microbial eczema and to evaluate the clinical efficacy and safety of the cream “Tetraderm” in such patients.
Materials and methods. Patients with microbial eczema were observed, randomly selected into two groups. All patients studied biocenosis of the skin before and after treatment. Patients of the study group received topical therapy with the cream “Tetraderm”. External therapy for patients of the comparison group was carried out with cream of mometasone furoate in combination with erythromycin and clotrimazole ointments. The effectiveness of the therapy was evaluated taking into account the clinical dynamics of the skin process, bacteriological data on the content of pustules and detachable erosion, calculation of the EASI and DIJ indices.
Results. A comparative analysis of the biocenosis of microbial eczema foci in patients of both groups at the end of therapy showed a higher severity of disbiotic changes in the comparison group. As a result of our study found that patients who used the cream “Tetraderm”, there was a more rapid regression of dermatosis, almost complete suppression of pathogenic bacterial flora, a significant improvement in the quality of life.
Conclusion. The biocenosis of the skin of patients with microbial eczema was characterized by a high degree of contamination of Staphylococcus aureus and Staphylococcus epidermidis, against the background of the average verification of Streptococcus spp., Candida spp. The combination of pronounced anti-inflammatory, antibacterial, antimicotic and regenerating effects of the cream “Tetraderm” causes its high efficiency and prospects of use as a drug of choice of topical monotherapy of microbial eczema.


M. M. Tlish

Kuban State Medical University

Email: fake@neicon.ru

Russian Federation

Dr. Sci. (Med.), Prof., Departmental Head, Department of Dermatovenereology

Rashpilevskaya str., 179, Krasnodar, 350000, Russian Federation

 

T. G. Kuznetsova

Kuban State Medical University

Author for correspondence.
Email: taya1504@mail.ru

Russian Federation

Cand. Sci. (Med.), Assistant, Department of Dermatovenereology

Rashpilevskaya str., 179, Krasnodar, 350000, Russian Federation

Z. Yu. Naatyzh

Kuban State Medical University

Email: fake@neicon.ru

Russian Federation

Cand. Sci. (Med.), Assistant, Department of Dermatovenereology

Rashpilevskaya str., 179, Krasnodar, 350000, Russian Federation

F. A. Psavok

Kuban State Medical University

Email: fake@neicon.ru

Russian Federation

Cand. Sci. (Med.), Assistant, Department of Dermatovenereology

Rashpilevskaya str., 179, Krasnodar, 350000, Russian Federation

  1. Kubanova A. A. (ed.) Dermatovenerology (Clinical guidelines. Russian society of dermatologists and venereologists). M.: DEKS-Press, 2010: 428.
  2. Haslund P., Bangsgaard N., Jarløv J. O. et al. Staphylococcus aureus and hand eczema severity. Br J Dermatol. 2009 Oct;161(4):772–777.
  3. Bartlett A. Adult eczema. Nurs Stand. 2010 Jun 30 — Jul 6;24(43):51.
  4. Nadarchenko R. M., Abdrahimova N. A. Imelbayeva E. A., Khismatullina Z. R. Improvement of diagnostic and treatment approaches to therapy numulyarnaya forms of microbial eczema. Russian Journal of Immunology. 2016;10(19):320–321.
  5. Biagini Myers J. M., Khurana Hershey G. K. Eczemainearly life: genetics, the skin barrier, and lessons learned from birth cohort studies. J Pediatr. 2010 Nov;157(5):704–714.
  6. Nikonova I. V, Orlov E. V., Konnov P. E. The state of biocenosis of the skin with microbial eczema. Practical Medicine. 2011;2:80–83.
  7. Nadarchenko R. M., Abdrahimova N. A. Imelbayeva E. A., Khismatullina Z. R., Gareev E. M. The Role of correction of the level of interleukin-1β in the treatment numulyarnaya microbial eczema. Russian Journal of Immunology. 2016;10(19):322–323.
  8. Abdrakhimova N. A., Mustafina G. R., Khismatullina Z. R., Zakharchenko V. D. Immunological concept of microbial eczema development. Medical Bulletin of Bashkortostan. 2014;9(1):109–118.

Views

Abstract - 299

PDF (Russian) - 75

Refbacks

  • There are currently no refbacks.

Copyright (c)



This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies